In an included MS study, miR-155 was elevated in T cells from patients with active multiple sclerosis, which correlated with lower expression of the SOCS1 gene (a suppressor of cytokine signaling) and skewing toward a T_H17 phenotype (44, 46, 47). This evidence concerns the gene SOCS1 and myeloid sarcoma.